Vestmark Advisory Solutions’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Vestmark Advisory Solutions’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-2,965	Closed	-$585K	–	562
2020 Q2	$585K	Buy	2,965 +30	+1%	+$6.21K	0.09%	273
2020 Q1	$575K	Buy	+2,935	New	+$632K	0.11%	238
2019 Q4	–	Sell	-2,806	Closed	-$428K	–	358
2019 Q3	$428K	Buy	2,806 +639	+29%	+$105K	0.07%	331
2019 Q2	$279K	Buy	2,167 +27	+1%	+$3.2K	0.05%	429
2019 Q1	$252K	Buy	+2,140	New	+$216K	0.04%	444

Other funds holding LKFT

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

Vestmark Advisory Solutions's LKFT Position: Q3 2020 in Review

Vestmark Advisory Solutions sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2020, closing a stake of 2,965 shares — an estimated $585K sold.

Vestmark Advisory Solutions first reported a position in LKFT in Q1 2019 and held it in 5 quarters. The position peaked at $585K in Q2 2020. 119 funds tracked by Wall St. Rank hold LKFT as of Q3 2020.

Vestmark Advisory Solutions reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Vestmark Advisory Solutions sold 2,965 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2020, an estimated $585K.
Vestmark Advisory Solutions first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2019 and held it in 5 quarters.
Vestmark Advisory Solutions's Lakefront Biotherapeutics American Depositary Shares position peaked at $585K in Q2 2020.
119 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2020.

Based on Vestmark Advisory Solutions's 13F filing for Q3 2020, filed 19 Oct 2020.